Literature DB >> 12424150

Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.

Janet M McComb, A John Camm.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12424150      PMCID： PMC1124563          DOI： 10.1136/bmj.325.7372.1050

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology.

Authors:  R N Hauer ; E Aliot; M Block; A Capucci; B Lüderitz; M Santini; P E Vardas
Journal:  Eur Heart J       Date:  2001-07       Impact factor: 29.983

Review 2.  Evidence-based analysis of amiodarone efficacy and safety.

Authors:  S J Connolly
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

3.  ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation).

Authors:  G Gregoratos; M D Cheitlin; A Conill; A E Epstein; C Fellows; T B Ferguson; R A Freedman; M A Hlatky; G V Naccarelli; S Saksena; R C Schlant; M J Silka; J L Ritchie; R J Gibbons; M D Cheitlin; K A Eagle; T J Gardner; R P Lewis; R A O'Rourke; T J Ryan; A Garson
Journal:  J Am Coll Cardiol       Date:  1998-04       Impact factor: 24.094

4.  Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.

Authors:  A E Buxton; K L Lee; L DiCarlo; M R Gold; G S Greer; E N Prystowsky; M F O'Toole; A Tang; J D Fisher; J Coromilas; M Talajic; G Hafley
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

5.  Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers.

Authors:  C Schmitt; P Barthel; G Ndrepepa; J Schreieck; A Plewan; A Schömig; G Schmidt
Journal:  J Am Coll Cardiol       Date:  2001-06-01       Impact factor: 24.094

6.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors:  A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

7.  Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era.

Authors:  S H Hohnloser; T Klingenheben; M Zabel; M Schöpperl; O Mauss
Journal:  J Am Coll Cardiol       Date:  1999-06       Impact factor: 24.094

8.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

9.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.

Authors:  A E Buxton; K L Lee; J D Fisher; M E Josephson; E N Prystowsky; G Hafley
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

10.  Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results.

Authors:  A P Maggioni; G Zuanetti; M G Franzosi; F Rovelli; E Santoro; L Staszewsky; L Tavazzi; G Tognoni
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.